Canada Purchases 76 Million Coronavirus Vaccine Doses

Maryland based Novavax, Inc. announced on August 31, 2020, it has reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.